V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20196503 | 20125222 | 1.73 | 80 | Curative (C) | 2018-10-28 | 2018-10-28 | CETUXIMAB | 02 | null | CETUXIMAB | 101277572 |
| 20196510 | 20125223 | 1.85 | 78.6 | Curative (C) | 2016-11-02 | 2016-11-16 | Cetuximab 14 day | 02 | N | TRASTUZUMAB | 101116603 |
| 20196511 | 20125224 | 1.88 | 74.5 | null | 2019-01-21 | 2019-02-18 | CETUXIMAB | N | null | CETUXIMAB | 100892528 |
| 20196515 | 20125225 | 1.84 | 66.9 | null | 2016-05-13 | 2016-05-15 | CETUXIMAB | 02 | Y | CAPECITABINE + CISPLATIN | 101063708 |
| 20196516 | 20125226 | 1.59 | 60.3 | Palliative (P) | 2016-09-20 | 2016-10-19 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100242055 |
| 20196519 | 20125227 | 1.43 | 46.05 | Curative (C) | 2019-06-25 | 2019-07-15 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100752596 |
| 20196523 | 20125228 | 1.79 | 66.6 | Palliative (P) | null | 2018-12-03 | Trastuzumab | N | N | TRASTUZUMAB | 101581761 |
| 20196524 | 20125229 | 1.7 | 117 | Curative (C) | 2016-02-09 | 2016-02-17 | Trastuzumab | 01 | Y | TRASTUZUMAB | 101163427 |
| 20196528 | 20125230 | 1.59 | 56.2 | Curative (C) | 2017-06-11 | 2017-06-11 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101396547 |
| 20196531 | 20125231 | 1.64 | 76.75 | null | 2019-08-03 | 2019-08-29 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101645211 |
| 20196534 | 20125232 | 1.65 | 88.5 | Palliative (P) | 2020-04-26 | 2020-05-15 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 101762408 |
| 20196537 | 20125233 | 1.7 | 69.2 | null | 2018-09-28 | 2018-10-05 | Trastuzumab 21 day maintenance | N | null | TRASTUZUMAB | 101583395 |
| 20196542 | 20125234 | 1.81 | 105.7 | Palliative (P) | 2020-04-07 | 2020-04-16 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100426991 |
| 20196544 | 20125235 | 1.7 | 124 | Palliative (P) | 2018-06-28 | 2018-10-06 | Trastuzumab | 02 | N | TRASTUZUMAB | 101762849 |
| 20196545 | 20125236 | 1.76 | 81.2 | Curative (C) | 2019-05-30 | 2019-08-13 | CETUXIMAB | 02 | N | CETUXIMAB | 101508001 |
| 20196547 | 20125237 | 1.8 | 62 | Adjuvant (A) | 2016-02-15 | 2021-03-09 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN | 101077014 |
| 20196548 | 20125238 | 1.65 | 70.8 | Palliative (P) | 2019-09-28 | 2019-10-19 | Capecitabine + Cisplatin | 99 | N | CAPECITABINE + CISPLATIN | 101592430 |
| 20196553 | 20125239 | 1.64 | null | Curative (C) | 2018-09-28 | 2018-10-19 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 101008293 |
| 20196561 | 20125240 | 1.84 | 60.8 | Palliative (P) | 2017-10-26 | 2017-11-07 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100719370 |
| 20196566 | 20125241 | 1.63 | 81.3 | null | 2020-01-31 | 2020-01-31 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101318502 |
| 20196567 | 20125242 | 1.75 | 54.9 | Curative (C) | 2016-07-31 | 2016-07-31 | Trastuzumab | N | N | TRASTUZUMAB | 100523149 |
| 20196569 | 20125243 | 1.66 | 56.2 | Neo-adjuvant (N) | 2016-09-17 | 2016-10-10 | CETUXIMAB | 02 | N | TRASTUZUMAB | 100120621 |
| 20196577 | 20125244 | 1.61 | 80 | null | 2016-05-20 | 2016-05-27 | Capecitabine + Cisplatin | 02 | 2 | CAPECITABINE + CISPLATIN | 101012131 |
| 20196585 | 20125245 | 1.72 | 43.5 | Palliative (P) | 2020-02-10 | 2020-02-28 | CETUXIMAB | N | N | TRASTUZUMAB | 101453818 |
| 20196587 | 20125246 | 1.85 | 95.6 | Curative (C) | 2017-05-05 | 2017-08-20 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100272387 |
| 20196595 | 20125247 | 1.66 | 85.15 | Adjuvant (A) | 2021-12-18 | 2021-12-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100739912 |
| 20196598 | 20125248 | 1.56 | 63.7 | Palliative (P) | 2019-12-11 | 2019-12-25 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 101181100 |
| 20196610 | 20125249 | 1.82 | 60 | Neo-adjuvant (N) | 2018-06-08 | 2018-06-12 | Trastuzumab | N | N | TRASTUZUMAB | 101667036 |
| 20196611 | 20125250 | 1.59 | 54 | Curative (C) | 2019-12-02 | 2019-12-02 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101205805 |
| 20196613 | 20125251 | 1.7 | 65.2 | Curative (C) | 2017-10-30 | 2017-11-17 | Trastuzumab 21 day maintenance | 02 | Y | TRASTUZUMAB | 100892417 |
| 20196614 | 20125252 | 1.72 | 75 | Curative (C) | 2020-06-18 | 2020-08-21 | CETUXIMAB | 02 | null | CETUXIMAB | 101521357 |
| 20196621 | 20125253 | 1.83 | 109 | Palliative (P) | 2017-10-08 | 2017-10-30 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100480977 |
| 20196624 | 20125254 | 1.74 | 94.2 | Curative (C) | 2020-02-01 | 2020-02-23 | Cetuximab 14 day | 02 | N | CAPECITABINE + CISPLATIN | 101671993 |
| 20196630 | 20125255 | 1.81 | 56.7 | Curative (C) | 2018-03-12 | 2018-03-13 | CETUXIMAB | 02 | N | CETUXIMAB | 101853470 |
| 20196633 | 20125256 | 0 | 87.8 | Neo-adjuvant (N) | 2020-01-23 | 2020-01-30 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100197357 |
| 20196641 | 20125257 | 1.73 | 81.2 | Curative (C) | null | 2016-06-03 | CETUXIMAB | N | N | CETUXIMAB | 101540856 |
| 20196644 | 20125258 | 1.66 | 84 | Palliative (P) | 2017-07-20 | 2018-01-26 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN | 100771960 |
| 20196646 | 20125259 | 1.73 | 75.9 | Curative (C) | 2017-11-16 | 2017-11-20 | CETUXIMAB | 02 | N | CETUXIMAB | 100292119 |
| 20196650 | 20125260 | 1.7 | 84.7 | 03 | 2019-08-07 | 2019-08-24 | Cetuximab 14 day | 02 | Y | CETUXIMAB | 101096128 |
| 20196654 | 20125261 | 1.54 | 79 | Curative (C) | 2019-05-24 | 2019-06-05 | Capecitabine + Cisplatin | 02 | Y | CAPECITABINE + CISPLATIN | 101550664 |
| 20196656 | 20125262 | 1.72 | 50 | Neo-adjuvant (N) | 2017-12-04 | 2017-12-11 | Capecitabine + Cisplatin | 02 | N | CAPECITABINE + CISPLATIN | 100692774 |
| 20196660 | 20125263 | 1.81 | 74 | Adjuvant (A) | 2019-08-23 | 2019-08-23 | Cetuximab 14 day | 99 | N | CETUXIMAB | 101579427 |
| 20196661 | 20125264 | 1.8 | 79.5 | Curative (C) | 2017-08-04 | 2017-08-31 | Trastuzumab | 02 | Y | TRASTUZUMAB | 101694040 |
| 20196662 | 20125265 | null | null | Curative (C) | 2016-09-06 | 2016-09-13 | Trastuzumab | 2 | null | TRASTUZUMAB | 101520004 |
| 20196670 | 20125266 | 1.66 | 77.3 | Neo-adjuvant (N) | 2017-03-12 | 2019-01-23 | CETUXIMAB | 02 | N | CAPECITABINE + CISPLATIN | 101742018 |
| 20196671 | 20125267 | 1.82 | 80.6 | null | 2019-01-26 | 2019-02-09 | Trastuzumab Subcutaneous | 02 | Y | TRASTUZUMAB | 101501028 |
| 20196675 | 20125268 | 1.72 | 86.25 | Curative (C) | 2017-11-09 | 2017-11-12 | Trastuzumab 21 day maintenance | 99 | N | TRASTUZUMAB | 101141329 |
| 20196679 | 20125269 | 1.61 | 63.4 | Palliative (P) | 2019-07-02 | 2019-07-09 | Trastuzumab 21 day maintenance | 02 | N | TRASTUZUMAB | 100935827 |
| 20196681 | 20125270 | 1.56 | 94.3 | Palliative (P) | 2016-10-04 | 2017-02-14 | Cetuximab 14 day | 02 | null | CETUXIMAB | 101667870 |
| 20196683 | 20125271 | 1.51 | 82 | Curative (C) | 2018-06-23 | 2018-07-14 | CETUXIMAB | 02 | N | CETUXIMAB | 101488493 |